Correlation Between Ultrashort Mid and Pharmaceuticals Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ultrashort Mid and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultrashort Mid and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultrashort Mid Cap Profund and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Ultrashort Mid and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultrashort Mid with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultrashort Mid and Pharmaceuticals Ultrasector.

Diversification Opportunities for Ultrashort Mid and Pharmaceuticals Ultrasector

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ultrashort and Pharmaceuticals is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Ultrashort Mid Cap Profund and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Ultrashort Mid is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultrashort Mid Cap Profund are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Ultrashort Mid i.e., Ultrashort Mid and Pharmaceuticals Ultrasector go up and down completely randomly.

Pair Corralation between Ultrashort Mid and Pharmaceuticals Ultrasector

Assuming the 90 days horizon Ultrashort Mid Cap Profund is expected to under-perform the Pharmaceuticals Ultrasector. In addition to that, Ultrashort Mid is 1.11 times more volatile than Pharmaceuticals Ultrasector Profund. It trades about -0.11 of its total potential returns per unit of risk. Pharmaceuticals Ultrasector Profund is currently generating about -0.01 per unit of volatility. If you would invest  2,623  in Pharmaceuticals Ultrasector Profund on September 16, 2024 and sell it today you would lose (44.00) from holding Pharmaceuticals Ultrasector Profund or give up 1.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Ultrashort Mid Cap Profund  vs.  Pharmaceuticals Ultrasector Pr

 Performance 
       Timeline  
Ultrashort Mid Cap 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ultrashort Mid Cap Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Pharmaceuticals Ultrasector 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharmaceuticals Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Pharmaceuticals Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Ultrashort Mid and Pharmaceuticals Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ultrashort Mid and Pharmaceuticals Ultrasector

The main advantage of trading using opposite Ultrashort Mid and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultrashort Mid position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.
The idea behind Ultrashort Mid Cap Profund and Pharmaceuticals Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing